powered help
header-left header-center header-right
Share to Facebook Share to Twitter Bookmark and Share
File #: 210503    Version:
Type: Resolution Status: Passed
File created: 7/27/2021 In control: COMMON COUNCIL
On agenda: Final action: 9/21/2021
Effective date:    
Title: Substitute Resolution relative to the acceptance and funding of the 2021-2023 Impact of immune failure on SARS-CoV-2 evolutionary potential Grant from University of Wisconsin System and Center for Disease Control (CDC).
Sponsors: THE CHAIR
Indexes: GRANTS, PUBLIC HEALTH
Attachments: 1. Grant analysis-CDC COVID Immune Failure 2021-23.pdf, 2. Grant budget-CDC COVID Immune Failure 2021-23.pdf, 3. EIS-Lab CDC COVID Immune Failure.pdf, 4. Hearing Notice List
Date Ver.Action ByActionResultTallyAction DetailsMeeting DetailsVideo
9/22/20211 MAYOR SIGNED   Action details Meeting details Not available
9/21/20211 COMMON COUNCIL ADOPTEDPass15:0 Action details Meeting details Video Video
9/15/20211 FINANCE & PERSONNEL COMMITTEE RECOMMENDED FOR ADOPTION

Minutes note: Appearing: Nicholas Bolden, Health Dept. Sanjib Bhattacharyya, Health Dept.
Pass5:0 Action details Meeting details Video Video
9/10/20211 PUBLIC SAFETY AND HEALTH COMMITTEE RECOMMENDED FOR ADOPTION AND ASSIGNEDPass3:0 Action details Meeting details Video Video
7/27/20210 COMMON COUNCIL ASSIGNED TO   Action details Meeting details Not available
Number
210503

Version
Substitute 1

Reference

Sponsor
The Chair

Title
Substitute Resolution relative to the acceptance and funding of the 2021-2023 Impact of immune failure on SARS-CoV-2 evolutionary potential Grant from University of Wisconsin System and Center for Disease Control (CDC).

Analysis
This resolution authorizes the Health Department to accept and fund the 2021-2023 Impact of immune failure on SARS-CoV-2 evolutionary potential Grant from University of Wisconsin System and Center for Disease Control (CDC) in the amount of $488,970 100% grantor share. The purpose of the grant is to focus on utilizing viral genome sequencing for SARS-CoV-2 to better understand the emergence and spread of SARS-CoV-2 variants arising as a result of immune failure.

Body
Whereas, the City of Milwaukee appears to be eligible for grant funds from the University of Wisconsin System and Center for Disease Control (CDC) to focus on utilizing viral genome sequencing for SARS-CoV-2 to better understand the emergence and spread of SARS-CoV-2 variants arising as a result of immune failure; and

Whereas, The continued operation of this grant program from 04.01.2021 to 03.31.2023 would cost $488,970 comprised of $488,970 (100%) grantor share; now, therefore, be it

Resolved, By the Common Council of the City of Milwaukee, that application of this grant from the University of Wisconsin System and Center for Disease Control (CDC) is authorized and the Health Department shall accept this grant without further approval unless the terms of the grant change as indicated in Milwaukee Code of Ordinances Section 304-81; and, be it

Further Resolved, That the City Comptroller is authorized to:

1. Commit funds within the Project/Grant parent of the 2021 Special Revenue Grant and Aid Projects Fund, the following amounts for the program titled 2023 Impact of immune failure on SARS-CoV-2 evolutionary potential Grant:

Project/Grant GR0002100000
Fund 0150
Org 9990
Progra...

Click here for full text